Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone stimulating small molecule, which is in Phase 2b clinical trial for the treatment of pediatric growth hormone deficiency. The company was founded in 2011 and is headquartered in Austin, Texas.
IPO Year: 2011
Exchange: NASDAQ
Website: lumos-pharma.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/4/2021 | $27.00 → $28.00 | Buy | HC Wainwright & Co. |
| 7/21/2021 | $34.00 → $27.00 | Buy | HC Wainwright & Co. |
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
HC Wainwright & Co. reiterated coverage of Lumos Pharma with a rating of Buy and set a new price target of $28.00 from $27.00 previously
HC Wainwright & Co. reiterated coverage of Lumos Pharma with a rating of Buy and set a new price target of $27.00 from $34.00 previously
Stifel upgraded Lumos Pharma from Hold to Buy and set a new price target of $24.00 from $4.00 previously
Stifel Nicolaus upgraded Lumos Pharma from Hold to Buy
15-12G - LUMOS PHARMA, INC. (0001126234) (Filer)
AW - LUMOS PHARMA, INC. (0001126234) (Filer)
EFFECT - LUMOS PHARMA, INC. (0001126234) (Filer)
EFFECT - LUMOS PHARMA, INC. (0001126234) (Filer)
EFFECT - LUMOS PHARMA, INC. (0001126234) (Filer)
EFFECT - LUMOS PHARMA, INC. (0001126234) (Filer)
EFFECT - LUMOS PHARMA, INC. (0001126234) (Filer)
POS AM - LUMOS PHARMA, INC. (0001126234) (Filer)
POS AM - LUMOS PHARMA, INC. (0001126234) (Filer)
POS AM - LUMOS PHARMA, INC. (0001126234) (Filer)
SC 13G - LUMOS PHARMA, INC. (0001126234) (Subject)
SC 13G/A - LUMOS PHARMA, INC. (0001126234) (Subject)
SC 13G - LUMOS PHARMA, INC. (0001126234) (Subject)
SC 13D/A - LUMOS PHARMA, INC. (0001126234) (Subject)
SC 13D/A - LUMOS PHARMA, INC. (0001126234) (Subject)
SC 13D/A - LUMOS PHARMA, INC. (0001126234) (Subject)
SC 13D/A - LUMOS PHARMA, INC. (0001126234) (Subject)
SC 13G/A - LUMOS PHARMA, INC. (0001126234) (Subject)
SC 13G/A - LUMOS PHARMA, INC. (0001126234) (Subject)
SC 13D/A - LUMOS PHARMA, INC. (0001126234) (Subject)